IL324832A - תכשיר רוקחות המכיל איבופרופן - Google Patents

תכשיר רוקחות המכיל איבופרופן

Info

Publication number
IL324832A
IL324832A IL324832A IL32483225A IL324832A IL 324832 A IL324832 A IL 324832A IL 324832 A IL324832 A IL 324832A IL 32483225 A IL32483225 A IL 32483225A IL 324832 A IL324832 A IL 324832A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
ibuprofen
composition according
acid
aqueous solution
Prior art date
Application number
IL324832A
Other languages
English (en)
Original Assignee
Ioulia Tseti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GR20230100444A external-priority patent/GR1010732B/el
Priority claimed from GR20230100623A external-priority patent/GR1010769B/el
Priority claimed from GR20230100733A external-priority patent/GR1010809B/el
Application filed by Ioulia Tseti filed Critical Ioulia Tseti
Publication of IL324832A publication Critical patent/IL324832A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL324832A 2023-06-02 2024-05-31 תכשיר רוקחות המכיל איבופרופן IL324832A (he)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GR20230100444A GR1010732B (el) 2023-06-02 2023-06-02 Φαρμακευτικη συνθεση ιβουπροφαινης και παρακεταμολης για απο του στοματος χορηγηση
GR20230100623A GR1010769B (el) 2023-07-27 2023-07-27 Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση
GR20230100733A GR1010809B (el) 2023-09-13 2023-09-13 Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
PCT/GR2024/000014 WO2024246565A2 (en) 2023-06-02 2024-05-31 Pharmaceutical composition comprising ibuprofen

Publications (1)

Publication Number Publication Date
IL324832A true IL324832A (he) 2026-01-01

Family

ID=91620953

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324832A IL324832A (he) 2023-06-02 2024-05-31 תכשיר רוקחות המכיל איבופרופן

Country Status (7)

Country Link
KR (1) KR20260020463A (he)
CN (1) CN121285367A (he)
AU (1) AU2024281739A1 (he)
IL (1) IL324832A (he)
JO (1) JOP20250280A1 (he)
MX (1) MX2025014463A (he)
WO (1) WO2024246565A2 (he)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0109281A1 (en) 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
ES2171110B1 (es) 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
KR20050055812A (ko) * 2003-12-09 2005-06-14 한국콜마 주식회사 불쾌한 맛을 차폐한 의약 조성물
CN100404025C (zh) 2005-01-14 2008-07-23 信谊药厂 含有盐酸曲马多和对乙酰氨基酚的口崩片及其制备方法
MX2009004203A (es) 2006-10-20 2009-07-02 Mcneil Ppc Inc Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
JP2008143807A (ja) * 2006-12-07 2008-06-26 Sato Pharmaceutical Co Ltd 感冒薬カプセル剤及びその製造方法
CN102006867A (zh) 2008-01-03 2011-04-06 沃根哈德研究中心 含有扑热息痛和布洛芬的口服药物混悬剂
PT2277546E (pt) 2009-07-23 2015-09-25 Uni Pharma Kleon Tsetis Pharmaceutical Lab S A Formulação de paracetamol injectável estável pronta a utilizar
CN101987199A (zh) * 2009-08-04 2011-03-23 北京利乐生制药科技有限公司 一种用于解热镇痛的注射用组合物
CN101991540A (zh) 2009-08-27 2011-03-30 杭州赛利药物研究所有限公司 一种布洛芬注射剂及其制备方法
SI2389923T1 (sl) 2010-05-19 2013-06-28 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stabilna, pripravljena za uporabo, injicirajoča paracetamol formulacija
SG189319A1 (en) * 2010-11-04 2013-05-31 Aft Pharmaceuticals Ltd A combination composition
CN102389423A (zh) 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种含有布洛芬钠盐的药用组合物
CN103751158A (zh) 2011-10-13 2014-04-30 胡鲸波 含有扑热息痛和布洛芬的口服药物混悬剂
PE20150083A1 (es) * 2012-03-16 2015-01-21 Cumberland Pharmaceuticals Inc Formulacion de ibuprofeno inyectable
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
TWI546087B (zh) 2014-11-06 2016-08-21 Everbright Pharmaceuticals S A R L Containing aqueous preparations of acetaminophen and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
KR102675664B1 (ko) * 2021-09-15 2024-06-17 구주제약주식회사 안정성이 향상된 프로피오닉산 계열 약물 및 안정화제를 포함하는 약학 조성물
CN114588107B (zh) * 2022-04-06 2023-04-18 河北一品生物医药有限公司 一种布洛芬赖氨酸盐注射液及其制备方法

Also Published As

Publication number Publication date
CN121285367A (zh) 2026-01-06
JOP20250280A1 (ar) 2025-11-13
WO2024246565A2 (en) 2024-12-05
MX2025014463A (es) 2026-01-07
KR20260020463A (ko) 2026-02-11
AU2024281739A1 (en) 2025-11-27
WO2024246565A3 (en) 2025-02-27

Similar Documents

Publication Publication Date Title
ES2908447T3 (es) Formulación de metotrexato
US11865180B2 (en) Levothyroxine formulations for oral use
JP4959335B2 (ja) メチルフェニデート溶液および関連する投与および製造方法
CN102264346A (zh) 用于通过颊透粘膜途径来施用降血脂药的制剂
RU2363462C2 (ru) Фармацевтическая композиция, содержащая 5-метил-2-(2′-хлор-6′-фторанилин)фенилуксусную кислоту
EP2277546A1 (en) Stable ready to use injectable paracetamol formulation
IL324832A (he) תכשיר רוקחות המכיל איבופרופן
CA3164495C (en) LIQUID COMPOSITION CONTAINING IBUPROFEN AND PHENYLEPHRINE
KR102563037B1 (ko) 고미가 차폐된 디클로페낙을 함유하는 약제학적 조성물
US12097178B2 (en) Methods of efficiently treating vitamin C deficiency-related diseases and other conditions
IE900512L (en) Pentamidine solutions
US20210213024A1 (en) Liquid compositions of aprepitant
RU2842648C1 (ru) Жидкая композиция, содержащая ибупрофен и фенилэфрин
GR1010732B (el) Φαρμακευτικη συνθεση ιβουπροφαινης και παρακεταμολης για απο του στοματος χορηγηση
JP2004269363A (ja) アセトアミノフェンを含有する安定な水性医薬組成物
GR1010809B (el) Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
WO2002041892A1 (en) Water-soluble liquid internal medicine
US20240197631A1 (en) Atomoxetine oral solution
HK40077494B (en) Liquid composition comprising ibuprofen and phenylephrine
HK40077494A (en) Liquid composition comprising ibuprofen and phenylephrine
HK1153400B (en) Stable ready to use injectable paracetamol formulation